Innate and adaptive immune dysregulation in women with recurrent implantation failure.

IVF Immune cells Pathophysiology RIF Treatment

Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 11 11 2023
accepted: 13 05 2024
medline: 2 6 2024
pubmed: 2 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

Recurrent implantation failure (RIF) is a condition where a woman fails to obtain pregnancy after multiple embryo transfer cycles, even with superior-quality blastocysts. There are various factors that can contribute to RIF, including immunologic disturbances. The immune system is extremely important during pregnancy. Immune cells such as T cells, B cells, natural killer (NK) cells, and macrophages (MQ) are present in the female reproductive tract and are accountable for regulating the immune response to invading pathogens and maintaining tissue homeostasis. Dysregulation of these immune cells can lead to inflammation, which can impair fertility. One of the most common immunological disturbances observed in RIF is an altered Th1/Th2 ratio, along with changes in NK cell and macrophage numbers. In addition, the presence of some antibodies, such as anti-ovarian antibodies, can also contribute to RIF. Interleukins have been implicated in the development of an inflammatory response that can interfere with successful embryo implantation. As a result, a comprehensive understanding of immunological compartments in RIF women could assist us in determining the immunological origins of this disease. We will discuss immunological factors that might contribute to RIF etiology, including cellular and molecular components.

Identifiants

pubmed: 38823361
pii: S0165-0378(24)00071-8
doi: 10.1016/j.jri.2024.104262
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104262

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Fateme Ebrahimi (F)

Department of Immunology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Alireza Omidvar-Mehrabadi (A)

Department of Immunology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Mehdi Shahbazi (M)

Department of Immunology, School of Medicine, Babol University of Medical Sciences, Babol, Iran. Electronic address: mehdishahbazi60@yahoo.com.

Mousa Mohammadnia-Afrouzi (M)

Department of Immunology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Classifications MeSH